Gold-nanobeacons for real-time monitoring of RNA synthesis

Biosensors and Bioelectronics

Volumn 36, Issue 1, 2012, Pages 161-167

  Rosa, João ^a   Conde, João ^a,b   de la Fuente, Jesus M ^b   Lima, João C ^a   Baptista, Pedro V ^a  

^a UNIVERSIDADE NOVA DE LISBOA   (Portugal)

^b UNIVERSITY OF ZARAGOZA   (Spain)

Author keywords

Fluorophore labeled hairpin DNA; Gold nanoparticles; Gold nanobecons; Inhibition of transcription; RNA synthesis

Indexed keywords

DIRECT METHOD; FLUORESCENCE EMISSION; FLUORESCENCE QUENCHING; FUNCTIONALIZED; GENE SILENCING; GOLD NANOPARTICLE; GOLD NANOPARTICLES; GOLD-NANOBECONS; IN-VITRO; IN-VITRO EVALUATION; IN-VIVO; PROMOTER SEQUENCES; QUANTITATIVE ASSESSMENTS; REACTION MIXTURE; REAL TIME; REAL TIME MONITORING; RNA SYNTHESIS;

BIOSENSORS; FLUORESCENCE; FLUOROPHORES; GENETIC ENGINEERING; GOLD; METAL NANOPARTICLES; SYNTHESIS (CHEMICAL); TRANSCRIPTION;

RNA;

GOLD NANOPARTICLE;

ARTICLE; BIOSENSOR; CONTROLLED STUDY; DNA HAIRPIN; DNA HYBRIDIZATION; ENZYME INHIBITION; GENE SILENCING; GOLD NANOBEACON; IN VITRO STUDY; MOLECULAR BEACON; PROMOTER REGION; QUANTITATIVE ANALYSIS; RNA SEQUENCE; RNA SYNTHESIS;

BIOSENSING TECHNIQUES; FLUORESCENCE; GENE SILENCING; GOLD; METAL NANOPARTICLES; NUCLEIC ACID HYBRIDIZATION; RNA;

EID: 84861653867     PISSN: 09565663     EISSN: 18734235     Source Type: Journal    
DOI: 10.1016/j.bios.2012.04.006     Document Type: Article

References (31)

1. Agbasi-Porter C., Ryman-Rasmussen J., Franzen S., et al. Bioconjugate Chemistry 2006, 17:1178-1183.
2. Agrawal S. Trends in Biotechnology 1996, 14:376-387.
3. Baptista P. Current Cancer Therapy Reviews 2009, 5:80-88.
4. Baptista P., Pereira E., Eaton P., et al. Analytical and Bioanalytical Chemistry 2008, 391:943-950.
5. Bor Y.C., Swartz J., Li Y., Coyle, et al. Nature Protocols 2006.
6. Cheng Y., Stakenborg T., Van Dorpe P., et al. Analytical Chemistry 2011, 83:1307-1314.
7. Conde J., de la Fuente J.M., Baptista P.V. Nanotechnology 2010, 21:1-6.
8. Dubertret B., Calame M., Libchaber A.J. Nature Biotechnology 2001, 19:365-370.
9. Fichou Y., Ferec C. Trends in Biotechnology 2006, 24:563-570.
10. Freeman W.M., Walker S.J., Vrana K.E. Biotechniques 1999, 26:112-115.
11. Lakowicz J.R. Plasmonics 2006, 1:5-33.
12. Lee P.C., Meisel D. The Journal of Physical Chemistry 1982, 86:3391-3395.
13. Li J.J., Fang X., Schuster S.M. Angewandte Chemie-International Edition 2000, 39:1049-1052.
14. Li J.J., Geyer R., Tan W. Nucleic Acids Research 2000, 28:1-6.
15. Liu J., Feldman P., Chung T.C. Analytical Biochemistry 2002, 300:40-45.
16. Luhtala N., Parker R. Nucleic Acids Research 2009, 37:5529-5536.
17. Marras S.A., Gold B., Kramer F.R., et al. Nucleic Acids Research 2004, 32:1-6.
18. Paciotti G.F., Myer L., Weinreich D., et al. Drug Delivery 2004, 11:169-183.
19. Quarta A., Di Corato R., Manna L., et al. IEEE Transactions on NanoBioscience 2007, 6:298-308.
20. Rayburn E.R., Zhang R. Drug Discovery Today 2008, 13:513-521.
21. Rosi N.L., Giljohann D.A., Thaxton C.S., et al. Science (New York, NY) 2006, 312:1027-1030.
22. Saha K., Agasti S.S., Kim C., et al. Chemical Reviews 2012, Article ASAP.
23. Schena M., Shalon D., Davis R.W., et al. Science (New York, NY) 1995, 270:467-470.
24. Seferos D.S., Giljohan D.A., Hill H.D., Prigodich, et al. Journal of the American Chemical Society 2007, 129:15477-15479.
25. Song S., Liang Z., Zhang J., et al. Angewandte Chemie-International Edition 2009, 48:8670-8674.
26. Tamm I., Dorken B., Hartmann G. Lancet 2001, 358:489-497.
27. Tan W., Wang K., Drake T.J. Current Opinion in Chemical Biology 2004, 8:547-553.
28. Toub N., Malvy C., Fattal E., Couvreur P. Biomedicine and Pharmacotherapy-Biomedecine and Pharmacotherapie 2006, 60:607-620.
29. Tyagi S., Kramer F.R. Nature Biotechnology 1996, 14:303-308.
30. Waltz T.L., Marras S., Rochford G., et al. Journal of Clinical Microbiology 2005, 43:254-258.
31. Weis J.H., Tan S.S., Martin B.K., et al. Trends in Genetics 1992, 8:263-264.